Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Siemens Healthineers Liver Fibrosis Test Gets FDA Breakthrough Device Designation

Siemens Healthineers Liver Fibrosis Test Gets FDA Breakthrough Device Designation

Nov 08, 2018
|
staff reporter

NEW YORK (360Dx) – Siemens Healthineers said today that the US Food and Drug Administration has granted Breakthrough Device designation for its Advia Centaur Enhanced Liver Fibrosis (ELF) test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. Chembio Nabs CE Mark for SARS-CoV-2 Tests, Inks Distribution Agreement with Luas Diagnostics

  2. Snibe Diagnostic Gets CE Mark for Coronavirus Neutralizing Antibody Assay

  3. Thermo Fisher Scientific Unit Phadia Gets FDA EUA for Coronavirus Antibody Test

  4. FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

  5. Ortho Clinical Diagnostics COVID-19 Antigen Test Receives FDA EUA for High-Volume Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.